STAA 8.95 Staar Surgical Company $STAA Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 7, 2014 at 11:15 PM

STAA 8.95 Staar Surgical Company $STAA Hit a 52 week low of 8.75 Closing the day 11/07/14 at 8.95 +0.07 +0.79% With a day low of 8.75 and a total volume of 235,159.

STAA Recent Posts: http://investorshangout.com/Staar-Surgical-Co...TAA-55532/

STAA Staar Surgical Company Recent Headline News

Commit To Purchase Staar Surgical At $7.50, Earn 17.4% Annualized Using Options
StockOptionsChannel.com - Fri Nov 07, 10:33AM CST
Investors considering a purchase of Staar Surgical Co. shares, but cautious about paying the going market price of $8.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
STAA: 8.95 (+0.07)

Shares of STAA Down 35.2% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Nov 06, 11:00AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 4 months, STAAR Surgical has returned 35.16% as of today's recent price of $9.00.
STAA: 8.95 (+0.07)

STAAR Surgical To Present At The Stephens 2014 Fall Investment Conference
PR Newswire - Thu Nov 06, 6:00AM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the Stephens 2014 Fall Investment Conference at the New York Palace Hotel on Tuesday, November 11 at 12:00 p.m. PT/3:00 p.m. ET.
STAA: 8.95 (+0.07)

Staar Surgical (STAA) Downgraded From Hold to Sell
at The Street - Wed Nov 05, 8:41AM CST
Staar Surgical STAA has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+. TheStreet Ratings Team has this to say about their recommendation:
STAA: 8.95 (+0.07)

Strong On High Volume: Staar Surgical (STAA)
at The Street - Tue Nov 04, 9:02AM CST
Trade-Ideas LLC identified Staar Surgical (STAA) as a strong on high relative volume candidate
STAA: 8.95 (+0.07)

STAAR Surgical Gains Final Step in Regulatory Approval for Visian® ICL(TM) with CentraFLOW® in China
PR Newswire - Tue Nov 04, 6:00AM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it has received the Approval Certification from CFDA to market its Visian ICL with CentraFLOW® technology in China effective November 3rd. The Visian ICL with CentraFLOW uses a proprietary port in the center of the ICL optic, KS-AquaPORT®, intended to optimize the flow of fluid within the eye without affecting the quality of vision. The CentraFLOW technology eliminates the need for surgeons to perform a YAG peripheral iridotomy procedure days before the ICL implant, simplifying the procedure and increasing patient comfort while providing the superior visual outcomes of the ICL.
STAA: 8.95 (+0.07)

Nasdaq stocks posting largest percentage decreases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
ASMI: 41.20 (-0.20), TRMB: 27.31 (-0.17), STAA: 8.95 (+0.07), SCYX: 9.00 (+0.10), EPAY: 25.20 (+0.20), AEGR: 21.58 (-0.40)

Downgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Fri Oct 31, 6:59AM CDT
STAAR Surgical (NASDAQ:STAA) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $11.04 on volume of 235,000 shares, above average daily volume of 199,000. Over the past year, STAAR Surgical has traded in a range of $9.98 to $19.74 and closed yesterday at $11.04, 11% above that low. Over the past week, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has declined 0.5%.
STAA: 8.95 (+0.07)

Staar Surgical posts 3Q loss
Automated Insights - Thu Oct 30, 5:07PM CDT
MONROVIA, Calif. (AP) _ Staar Surgical Co. (STAA) on Thursday reported a loss of $2.7 million in its third quarter.
STAA: 8.95 (+0.07)

STAAR Surgical Reports Third Quarter Results
PR Newswire - Thu Oct 30, 3:01PM CDT
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported revenue for the third quarter ended October 3, 2014 of $18.2 million, a 6.3% increase over $17.1 million reported for the third quarter of 2013. The results included quarterly sales of $10.6 million of the Company's Visian ICL product portfolio, $5.8 million of its IOL products and $1.8 million of its lower margin Other Product sales. The effect of foreign currency exchange reduced sales by $0.4 million during the quarter. On a constant currency basis, revenues grew 9% during the third quarter of 2014 compared to the third quarter of 2013.
STAA: 8.95 (+0.07)

Downtrend Call Working As STAAR Surgical Stock Falls 21.3% (STAA)
Comtex SmarTrend(R) - Thu Oct 30, 9:50AM CDT
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 4 months, STAAR Surgical has returned 21.25% as of today's recent price of $10.93.
STAA: 8.95 (+0.07)

STAAR Surgical Has Returned 26.4% Since SmarTrend Recommendation (STAA)
Comtex SmarTrend(R) - Thu Oct 23, 9:13AM CDT
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 4 months, STAAR Surgical has returned 26.40% as of today's recent price of $10.22.
STAA: 8.95 (+0.07)

STAAR Surgical Announces Third Quarter 2014 Results Release Date, Conference Call And Webcast
PR Newswire - Thu Oct 23, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the third quarter ended October 3, 2014 on Thursday, October 30, 2014 after the market close.
STAA: 8.95 (+0.07)

STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting
PR Newswire - Fri Oct 17, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that the Company will webcast its presentation at an Investor Breakfast Meeting on Saturday, October 18, 7:00 a.m. CT at the American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, IL.
STAA: 8.95 (+0.07)

Shares of STAA Down 17.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 15, 5:35PM CDT
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 3 months, STAAR Surgical has returned 17.15% as of today's recent price of $11.50.
STAA: 8.95 (+0.07)

STAAR Surgical Has Returned 18.0% Since SmarTrend Recommendation (STAA)
Comtex SmarTrend(R) - Wed Oct 08, 4:59PM CDT
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 3 months, STAAR Surgical has returned 18.01% as of today's recent price of $11.38.
STAA: 8.95 (+0.07)

STAAR Surgical CEO Barry G. Caldwell to step down in March 2015
M2 - Mon Oct 06, 7:27AM CDT
Implantable lenses company STAAR Surgical Company (NasdaqGM:STAA) reported on Sunday the planned retirement of its president & CEO Barry G. Caldwell on 1 March 2015.
STAA: 8.95 (+0.07)

STAAR Surgical CEO to Retire in March 2015
PR Newswire - Fri Oct 03, 3:15PM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that Barry G. Caldwell, President & CEO (64), will retire on March 1, 2015. The Board of Directors has initiated a search to identify Mr. Caldwell's replacement. Mr. Caldwell will continue to lead the Company, serve on the Board of Directors and assist in the leadership transition process. In addition, effective with this retirement, Mr. Caldwell will become a consultant to STAAR through March 1, 2016.
STAA: 8.95 (+0.07)

STAAR Surgical Company (STAA) Stock Research Links

STAA Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Max Stock Expands with Strategic Logistics Center

Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...

PROCEPT Faces Legal Storm Over Sales Practices Missteps

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Rodeo Dental Gears Up for National Growth Surge

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

Ohio's Visionary Leadership Honored with Prestigious Award

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Aesthetic M&A: Graper Harper's New Future Unfolds

Charlotte's Premier Practice Takes a Strategic Leap Graper Harper Cosmetic Surgery's recent partnership with Aesthetic Partners might not be the headline grabbing Wall Street tale we've grown accustomed to, but it's certainly worth noting. When a practice like Graper Harper, recognized as a jewel in Charlotte's cosmetic landscape, teams up with a player like Aesthetic...

Pentair Faces Class Action Over Fraud Allegations

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Nonprofit Option Rises for Specialty Physicians

Reimaging Choices for Specialty Physicians In the whirlwind of healthcare, specialty physicians often find themselves between a rock and a hard place. The traditional paths are either hug a major health system or auction off to private equity, each option chaining them to systems more interested in the balance sheet than in patient care. But now, a third door opens. One...

EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

FirstEnergy's Bold Move: Dormo Joins to Boost Power

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Mental Health Lab Aims to Boost Workforce Resilience

Redefining Workforce Mental Health It’s about time someone shook up how we tackle workforce mental health. Enter Project Healthy Minds and their newly minted Workforce Lab, roping in some of the big dogs like Acast, KPMG, and L'Oréal USA. They've tagged Harvard Business School gurus to churn out data on what helps—or harms—workplace sanity. Finally, a chance to put...